Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure
Blood Purification · 2025
DOI: 10.1159/000548502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2025. Verfasst von Gabriel Chan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Acetaminophen, Continuous Renal Replacement Therapy, Phosphates, Liver Failure, Acute. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Hypophosphataemia is common in acute liver failure (ALF) and may worsen during continuous renal replacement therapy (CRRT) with phosphate-free fluids. We aimed to evaluate the safety and efficacy of Phoxilium®, a phosphate-containing CRRT fluid.
Methods
We conducted a retrospective single-center cohort study of paracetamol-induced ALF patients treated with CRRT between January 2018 and May 2024 as our ICU transitioned from Accusol® to Phoxilium®. We obtained data on demographics, biochemistry, and outcomes. We compared biochemical variables every 6 h up to 48 h post-CRRT initiation and then every 12 h until 168 h. The primary outcome was the occurrence of severe hypophosphataemia (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia.
- Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.
- School of Nursing and Health Sciences, RMIT University, Melbourne, Victoria, Australia.
- Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Victoria, Australia.
- Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia, ary.serpaneto@monash.edu.
- Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia, ary.serpaneto@monash.edu.
Zitieren
APA
Chan, G., Fisher, C., Baldwin, I. C., Warrillow, S. J., Chaba, A., Bellomo, R., & Serpa Neto, A. (2025). Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure. Blood Purification. https://doi.org/10.1159/000548502
Vancouver
Chan G, Fisher C, Baldwin IC, Warrillow SJ, Chaba A, Bellomo R, et al. Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure. Blood Purification. 2025. doi:10.1159/000548502
BibTeX
@article{Chan2025,
author = {Chan, Gabriel and Fisher, Caleb and Baldwin, Ian C and Warrillow, Stephen Joseph and Chaba, Anis and Bellomo, Rinaldo and Serpa Neto, Ary},
title = {Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure},
journal = {Blood Purification},
year = {2025},
doi = {10.1159/000548502}
}
EUVIMED